Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

High Serum Advanced Glycation End-Products Predict Coronary Artery Disease Irrespective of Arterial Stiffness in Diabetic Patients

  • Won, Ki-Bum (Department of Cardiology, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Chang, Hyuk-Jae (Department of Cardiology, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Park, Sung-Ha (Department of Cardiology, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Hong, Sung-Yu (Department of Cardiology, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Jang, Yang-Soo (Department of Cardiology, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Chung, Nam-Sik (Department of Cardiology, Yonsei Cardiovascular Center, Yonsei University College of Medicine)
  • Published : 2012.05.31
⟨ Previous Next ⟩

Abstract

Background and Objectives: Advanced glycation end-products (AGEs) contribute to the development of atherosclerosis. We investigated whether serum AGEs are related to the presence or severity of coronary artery disease (CAD), and explored the association between serum AGEs and arterial stiffness according to diabetes status in patients suspected of having CAD. Subjects and Methods: The measurement of serum AGEs and brachial-ankle pulse wave velocity (baPWV) were performed in 145 consecutive patients ($63{\pm}9$ years, 58% men) who received a coronary angiogram for evaluation of CAD. Results: Forty-four diabetics and 101 non-diabetics were classified into three subgroups based on the number of diseased vessels with obstructive CAD: 0, 1, and 2 or more vessel diseases (VDs). Serum AGEs were significantly higher in diabetics with obstructive CAD than in those without obstructive CAD ($2.16{\pm}0.29$ vs. $1.85{\pm}0.29\;mU/mL$, p=0.010) and were significantly correlated with the number of VDs only in diabetics (r=0.504, p<0.001). Serum AGEs were not significantly correlated with baPWV in diabetics or non-diabetics. In receiver operating characteristics analysis, the cut-off value of serum AGEs as a predictor of obstructive CAD was 1.98 mU/mL, with 64% sensitivity and 63% specificity in diabetics. In multiple regression analysis, serum AGEs independently predicted obstructive CAD and were associated with the number of VDs in diabetics. Conclusion: Serum AGEs independently predict obstructive CAD and the severity of coronary atherosclerosis irrespective of arterial stiffness only in diabetics. Evaluation of PWV and serum AGEs together may be more effective to identify the risk of CAD in diabetic individuals.

Keywords

References

  1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035-8. https://doi.org/10.1001/jama.1979.03290450033020
  2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34. https://doi.org/10.1056/NEJM199807233390404
  3. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316:823-8. https://doi.org/10.1136/bmj.316.7134.823
  4. De Vegt F, Dekker JM, Ruhe HG, et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999;42:926-31. https://doi.org/10.1007/s001250051249
  5. Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 1997;99:457-68. https://doi.org/10.1172/JCI119180
  6. Reddy GK. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res 2004;68:132-42. https://doi.org/10.1016/j.mvr.2004.04.002
  7. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005;111:3384-90. https://doi.org/10.1161/CIRCULATIONAHA.104.483628
  8. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006;113:657-63. https://doi.org/10.1161/CIRCULATIONAHA.105.555235
  9. Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 1999;22:1543-8. https://doi.org/10.2337/diacare.22.9.1543
  10. Kiuchi K, Nejima J, Takano T, Ohta M, Hashimoto H. Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart 2001;85: 87-91. https://doi.org/10.1136/heart.85.1.87
  11. Kanauchi M, Tsujimoto N, Hashimoto T. Advanced glycation end products in nondiabetic patients with coronary artery disease. Diabetes Care 2001;24:1620-3. https://doi.org/10.2337/diacare.24.9.1620
  12. Semba RD, Najjar SS, Sun K, Lakatta EG, Ferrucci L. Serum carboxymethyl- lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults. Am J Hypertens 2009; 22:74-9. https://doi.org/10.1038/ajh.2008.320
  13. Choi EY, Kwon HM, Ahn CW, et al. Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients. Yonsei Med J 2005;46:78-85. https://doi.org/10.3349/ymj.2005.46.1.78
  14. Tarchalski J, Guzik P, Wysocki H. Correlation between the extent of coronary atherosclerosis and lipid profile. Mol Cell Biochem 2003;246: 25-30. https://doi.org/10.1023/A:1023443609730
  15. Tanaka S, Avigad G, Brodsky B, Eikenberry EF. Glycation induces expansion of the molecular packing of collagen. J Mol Biol 1988;203: 495-505. https://doi.org/10.1016/0022-2836(88)90015-0
  16. Tsilibary EC, Charonis AS, Reger LA, Wohlhueter RM, Furcht LT. The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J Biol Chem 1988;263: 4302-8.
  17. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002;39:10-5. https://doi.org/10.1161/hy0102.099031
  18. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 2005;46:454-62. https://doi.org/10.1161/01.HYP.0000177474.06749.98
  19. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991;87:432-8. https://doi.org/10.1172/JCI115014
  20. Bucala R, Makita Z, Vega G, et al. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci U S A 1994; 91:9441-5. https://doi.org/10.1073/pnas.91.20.9441
  21. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A 1990;87: 9010-4. https://doi.org/10.1073/pnas.87.22.9010
  22. Yan SD, Schmidt AM, Anderson GM, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994;269:9889-97.
  23. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008;196:9-21. https://doi.org/10.1016/j.atherosclerosis.2007.07.025
  24. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001; 280:E685-94.
  25. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A 1993;90:6434-8. https://doi.org/10.1073/pnas.90.14.6434
  26. Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano K, Tsukada Y. Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res Clin Pract 1998;41:131-7. https://doi.org/10.1016/S0168-8227(98)00074-6
  27. Makita Z, Radoff S, Rayfield EJ, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325:836-42. https://doi.org/10.1056/NEJM199109193251202
  28. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002;25:359-64. https://doi.org/10.1291/hypres.25.359
  29. Sugawara J, Hayashi K, Yokoi T, et al. Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens 2005;19: 401-6. https://doi.org/10.1038/sj.jhh.1001838

Cited by

  1. Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort vol.12, pp.None, 2012, https://doi.org/10.1186/1475-2840-12-162
  2. Arterial stiffness and wave reflections in relation to plasma advanced glycation end products in a Chinese population. vol.26, pp.6, 2012, https://doi.org/10.1093/ajh/hpt014
  3. Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria vol.37, pp.5, 2012, https://doi.org/10.2337/dc13-2357
  4. Quantitative determination of @?-N-carboxymethyl-l-lysine in human plasma by liquid chromatography-tandem mass spectrometry vol.90, pp.None, 2012, https://doi.org/10.1016/j.jpba.2013.11.003
  5. Increased serum concentrations of Nɛ-carboxymethyllysine are related to the presence and the severity of rheumatoid arthritis vol.55, pp.4, 2018, https://doi.org/10.1177/0004563217733500
  6. Usability of Achilles tendon strain elastography for the diagnosis of coronary artery disease vol.46, pp.3, 2012, https://doi.org/10.1007/s10396-019-00931-9
  7. Advanced Glycation End Products and Risks for Chronic Diseases: Intervening Through Lifestyle Modification vol.13, pp.4, 2012, https://doi.org/10.1177/1559827617708991